Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · NECLIFE

NECTAR LIFE

HealthcarePharmaceuticals & Biotechnology₹194 cr market cap
₹9.98 ▼ -0.1% today As of 19 Nov 2026
52-week low ₹9.3052-week high ₹22.25

-55.1% from the 52-week high · +7.4% above the low

Nectar Lifesciences Ltd. is a holding company, which engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The company went IPO on 2005-07-19. The firm has developed fully integrated sustainable production systems to manufacture cephalosporin intermediates, active pharmaceuticals ingredients (APIs) and finished dosage formulations (FDF or Formulations) to meet the diverse requirements of its customer base in India and approximately 75 countries worldwide. The firm operates only in the business segment of Pharmaceuticals Products. The Company’s products include Cefixime, Cefuroxime Axetil, Ceftriaxone Sodium, and Menthol and its derivatives. The Company’s subsidiaries include Nectar Lifesciences USA, LLC; Nectar Lifesciences UK Limited, United Kingdom and Neclife PT, Unipessoal LDA, Portugal.

The short version. Return on equity was -50.3% in Mar 2026. Promoter holding was 51.84% in Sep 2026, up 7.31 points over 8 quarters.

1 · The price

How has the stock traded?

NECTAR LIFE trades 55.1% below its 52-week high and 7.4% above its 52-week low.

Change over period: —

1M-9.7%
3M-5.0%
6M-18.6%
1Y-27.1%

2 · The business

Is it growing?

Net margin24763.6%

28286.1 pts higher than a year earlier.

3-year growth129.7% profit

Revenue compounded at -81.9% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue00815281431455
Net profit3-15-6814-176-63-1308
Net margin %24763.6-106191.0-896.12159.5-3522.5-22.5-30.21.7
EPS (₹)0.14-0.79-3.50.64-7.85-2.82-5.80.35

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue91673168615251669154423672783
Net profit-293-1145-2425-733248
Net margin %-3152.5-6.80.3-1.61.5-4.71.31.7
EPS (₹)-15.08-5.070.22-1.081.12-3.271.422.12

3 · The quality

How well does it turn capital into profit?

Return on equity was -50.3% in Mar 2026; debt to equity is 0.00.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %-50.3-11.90.5-2.3
Return on capital %-8.7-8.58.62.9
EBITDA margin %-553.4-1.59.86.1
Net margin %-3152.4-6.80.3-1.5

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-81.9%-64.0%
Profit CAGR129.7%31.9%
Debt to equity0.00
Interest cover-1.4x
Current ratio9.71
P/E ratio0.9

4 · The owners

Who holds it, and are they adding?

Promoter holding51.84%

Up 7.31 pts over 8 quarters.

Foreign institutions0.5%

Down 0.23 pts over 8 quarters.

Domestic institutions3.9%

Up 3.9 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter44.5344.5344.5344.9144.9151.8451.8451.84+7.31
FII0.731.650.810.620.520.60.50.5-0.23
DII00.160.190.095.824.013.743.9+3.9
Public54.7253.6554.4454.3748.7343.5243.8943.74-10.98

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for NECTAR LIFE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about NECTAR LIFE

What is the NECTAR LIFE share price?

NECTAR LIFE (NECLIFE) last closed at ₹9.98, down 0.1% on the day. Its 52-week range is ₹9.30 to ₹22.25.

What is the market cap of NECTAR LIFE?

NECTAR LIFE has a market capitalisation of about ₹194 crore. Its price-to-earnings ratio is 0.9.

How are NECTAR LIFE's latest results?

Return on equity was -50.3% in Mar 2026. Promoter holding was 51.84% in Sep 2026, up 7.31 points over 8 quarters.

Who owns NECTAR LIFE?

As of Sep 2026, shareholding was: Promoter 51.84%, FII 0.5%, DII 3.9%, Public 43.74%.

How many mutual funds hold NECTAR LIFE?

0 mutual fund schemes held NECTAR LIFE in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 11 Sep 2020 · Final Dividend - Rs. 0.05
  • 19 Sep 2019 · Final Dividend - Rs. 0.05
  • 19 Sep 2018 · Final Dividend - Rs. 0.05
  • 20 Sep 2017 · Final Dividend - Rs. 0.05
  • 22 Sep 2016 · Final Dividend - Rs. 0.1
  • 22 Sep 2015 · Final Dividend - Rs. 0.1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.